Lymphatic Filariasis: Progress Towards Elimination

Lymphatic Filariasis: Progress Towards Elimination

Preventive chemotherapy (PC) is now a widely used strategy to treat populations at risk of helmin-thic diseases to prevent its transmission and to reduce morbidity among those affected by it. PC is now elim-ination/control strategies for lymphatic filariasis (LF), soil-transmitted helminthi...

Full description

Saved in:

Bibliographic Details
Main Author:	Ranganath BG
Format:	Article
Language:	English
Published:	Sri Devaraj Urs Academy of Higher Education and Research 2016-06-01
Series:	Journal of Clinical and Biomedical Sciences
Online Access:	https://jcbsonline.ac.in/articles/lymphatic-filariasis-progress-towards-elimination
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Elimination of lymphatic filariasis in the Gambia.
by: Maria P Rebollo, et al.
Published: (2015-03-01)

First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
by: Hugues C Nana-Djeunga, et al.
Published: (2017-06-01)

Toward the elimination of lymphatic filariasis in the Democratic Republic of Congo: progress, perspectives, and strategic directions
by: Sylvain Mupoyi, et al.
Published: (2025-06-01)

Elimination of lymphatic filariasis as a public health problem in Malawi.
by: John Chiphwanya, et al.
Published: (2024-02-01)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal.
by: Chet Raj Ojha, et al.
Published: (2017-07-01)

Costs of Transmission Assessment Surveys to Provide Evidence for the Elimination of Lymphatic Filariasis.
by: Molly A Brady, et al.
Published: (2017-02-01)

Global programme to eliminate lymphatic filariasis: the processes underlying programme success.
by: Kazuyo Ichimori, et al.
Published: (2014-12-01)

Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis.
by: Pamela J Hooper, et al.
Published: (2014-11-01)

Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana.
by: Nana-Kwadwo Biritwum, et al.
Published: (2017-05-01)

Diagnostics to support elimination of lymphatic filariasis-Development of two target product profiles.
by: Kimberly Y Won, et al.
Published: (2021-11-01)

Towards global elimination of lymphatic filariasis: a systematic review of the application of spatial epidemiological methods to enhance surveillance and support elimination programmes
by: Angela Cadavid Restrepo, et al.
Published: (2024-05-01)

Application of the Filariasis CELISA Antifilarial IgG𝟒 Antibody Assay in Surveillance in Lymphatic Filariasis Elimination Programmes in the South Pacific
by: Hayley Joseph, et al.
Published: (2011-01-01)

Global insights can accelerate India’s journey towards the elimination of lymphatic filariasis as a public health problem
by: Manju Rahi, et al.
Published: (2025-07-01)

Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis.
by: Wilma A Stolk, et al.
Published: (2013-01-01)

Brazil was certified by the World Health Organization for having eliminated lymphatic filariasis: what now?
by: Eduardo Brandão, et al.
Published: (2025-03-01)

Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.
by: Daniel J Tisch, et al.
Published: (2011-07-01)

Cost-effectiveness of vector control for supplementing mass drug administration for eliminating lymphatic filariasis in India.
by: Donald S Shepard, et al.
Published: (2024-12-01)

Issues in Delivering Morbidity Management for Lymphatic Filariasis Elimination: A Study in Pondicherry, South India
by: A. Krishna Kumari, et al.
Published: (2012-01-01)

Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicators.
by: Nana-Kwadwo Biritwum, et al.
Published: (2017-03-01)

Lymphatic Filariasis Disseminating to the Upper Extremity
by: Catherine Maldjian, et al.
Published: (2014-01-01)

Lymphatic filariasis elimination in Kenya: Tracing the journey from 2002-2024 and pathways to achieving 2030 target
by: Michael Ofire Ofire, et al.
Published: (2025-03-01)

The Impact of Mass Drug Administration on Lymphatic Filariasis
by: Isaac Frimpong Aboagye, et al.
Published: (2022-01-01)

Mapping the geographical distribution of lymphatic filariasis in Zambia.
by: Enala T Mwase, et al.
Published: (2014-02-01)

Postelimination Cluster of Lymphatic Filariasis, Futuna, 2024
by: Clément Couteaux, et al.
Published: (2025-03-01)

Mass drug administration to eliminate lymphatic filariasis: A population-based coverage and compliance study in Eastern India
by: Shubhashisha Mohanty, et al.
Published: (2024-11-01)

Molecular xenomonitoring of Wuchereria bancrofti infection in three different evaluation settings of lymphatic filariasis elimination programme in India
by: Venkatesan Vasuki, et al.
Published: (2025-03-01)

Nutritional predictors of lymphatic filariasis progression: Insights from a machine learning approach.
by: Emmanuel Kobla Atsu Amewu, et al.
Published: (2025-01-01)

The effects of variable spatial aggregation on lymphatic filariasis transmission
by: Callum Shaw, et al.
Published: (2025-01-01)

Lymphatic Endothelial Cell in Endemic Bancroftian Filariasis: A Focus on the Lymphatics of the Tunica Vaginalis Testis
by: Jose Figueredo-Silva, et al.
Published: (2018-01-01)

Assessment of transmission in areas of uncertain endemicity for lymphatic filariasis in Brazil.
by: Amanda Xavier, et al.
Published: (2019-11-01)

Lymphatic filariasis as an indigenous illness: the local context of a global disease
by: Jonathan Roberts, et al.
Published: (2025-12-01)

Confirmatory mapping for lymphatic filariasis in districts previously considered nonendemic in Ghana
by: Joseph L. Opare, et al.
Published: (2025-03-01)

Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
by: Christina A Bulman, et al.
Published: (2015-02-01)

Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis.
by: Anandharaman Veerapathran, et al.
Published: (2009-06-01)

Epidemiological monitoring survey to assess the impact of mass drug administration with triple-drug regimen in lymphatic filariasis elimination programme in an endemic district in Southern India.
by: Kaliannagounder Krishnamoorthy, et al.
Published: (2025-08-01)

The significant scale up and success of Transmission Assessment Surveys 'TAS' for endgame surveillance of lymphatic filariasis in Bangladesh: One step closer to the elimination goal of 2020.
by: A K M Shamsuzzaman, et al.
Published: (2017-01-01)

New Results on the Asymptotic Behaviour of a Stochastic SEI Model of Lymphatic Filariasis
by: Ragnimwendé Sawadogo, et al.
Published: (2024-01-01)

Editorial: Morbidity management of lymphatic filariasis: a focus on filarial hydrocele and lymphoedema
by: Sunny Doodu Mante, et al.
Published: (2025-05-01)

Validation of routine lymphatic filariasis morbidity surveillance in the Upper West Region, Ghana.
by: Hope Simpson, et al.
Published: (2025-01-01)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
by: Nana O Wilson, et al.
Published: (2016-12-01)